An NIH intramural percubator as a model of academic-industry partnerships: From the beginning of life through the valley of death

Journal of Translational Medicine

Volumn 9, Issue , 2011, Pages

  Emmert Buck, Michael R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMMERCIAL PHENOMENA; GOVERNMENT; HOSPITAL; INDUSTRY; LABORATORY; NATIONAL HEALTH ORGANIZATION; NOTE; PUBLIC-PRIVATE PARTNERSHIP; TRANSLATIONAL RESEARCH; COOPERATION; EDITORIAL; THEORETICAL MODEL; UNITED STATES; UNIVERSITY;

COOPERATIVE BEHAVIOR; INDUSTRY; MODELS, THEORETICAL; NATIONAL INSTITUTES OF HEALTH (U.S.); TRANSLATIONAL RESEARCH; UNITED STATES; UNIVERSITIES;

EID: 79955643445     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-54     Document Type: Note

References (15)

1. Kaiser J. Rejecting "big science" tag, Collins sets five themes for NIH. Science 2009, 325:927.
2. Dolgin E. Collins sets out his vision for the NIH. Nature 2009, 460:939.
3. Collins FS. Opportunities for research and NIH. Science 2010, 327:36-37. 10.1126/science.1185055, 20044560.
4. Hughes ME, Peeler J, Hogenesch JB. Network dynamics to evaluate performance of an academic institution. Sci Transl Med 2010, 2:53ps49.
5. DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: New estimates of drug development costs. J Health Econ 2003, 22:151-185. 10.1016/S0167-6296(02)00126-1, 12606142.
6. Nusenblatt RB, Marincola FM, Schechter AN. Translational medicine - doing it backwards. J Transl Med 2010, 8:12. 10.1186/1479-5876-8-12, 2831830, 20132543.
7. Ioannidis JPA. Materializing research promises: opportunities, priorities and conflicts in translational medicine. J Transl Med 2004, 2:5. 10.1186/1479-5876-2-5, 343300, 14754464.
8. Pober JS, Neuhauser CS, Pober JM. Obstacles facing translational research in academic medical centers. J Fed Amer Soc Exp Biol 2001, 15:2303-13.
9. Silber MB. Driving drug discovery: The fundamental role of academic labs. Sci Transl Med 2010, 2:30cm16.
10. Scudellari M. The profits of nonprofit. The suprising results when drug development and altruism collide. The Scientist 2010, 25:54.
11. Stevens AJ, Jensen JJ, Wyller K, Kilgore PC, Chatterjee S, Rohrbaugh ML. The Role of Public-Sector Research in the Discovery of Drugs and Vaccines. N Engl J Med 2011, 364:535-41. 10.1056/NEJMsa1008268, 21306239.
12. Meyer A. Nonprofits benefit from for-profit practices. The Chicago Tribune 2009,
13. Nichols M. Some US charities need profits to survive-experts. Reuters 2010,
14. Will GF. Rev the scientific engine. Washington Post 2011,
15. Bluestein A, Barrett A. Why we need more funding for big science. Inc Magazine 2010,